Buying pressure lifts Injective price higher in today's trading

Traders Union
All News
Crypto
Injective surges 10.05% today to $4.28

Highlights

Injective's daily trading volume surged nearly 58% above its 30-day average as technical activity and participation grew.
Governance-driven supply reductions, integration of native USDC, and regulated futures are supporting ecosystem and derivatives adoption.
INJ/USD trades with strong short-term bullish momentum, but overbought indicators point to risk of a pullback within the $4.13–$4.51 range.

Volume surges as governance reforms and feature rollouts lift sentiment

Injective has seen increased daily trading volume, surpassing its 30-day average by nearly 58%, driven by ongoing technical market activity and heightened participation. Recent governance-led supply reductions and the integration of native USDC, along with the introduction of regulated futures markets, are further supporting network growth. The ecosystem continues to progress with a focus on decentralized derivatives and ongoing on-chain adoption.

Anton Kharitonov, expert at Traders Union, sees INJ’s current rally as momentum-driven yet precarious. He notes that the 10.05% surge is amplified by speculative excess, with the RSI and Stochastic RSI now deep in overbought territory. While recent network innovations and volume spikes may boost sentiment, he cautions that the asset remains capped below its 200-day average at $4.53. The absence of weekly buy signals and the risk of retracement signal potential downside. "Traders should consider scaling back exposure, as current price action reflects elevated risk of a pullback rather than sustainable upside," Kharitonov warns.

Viktoras Karapetjanc, expert at Traders Union, highlights that Injective’s fundamentals are strengthening alongside technical momentum. He points to robust trading volume and concrete ecosystem growth from USDC integration and regulated futures as catalysts for sustained adoption. Karapetjanc notes the bullish structure remains intact above $4.13, with opportunities for long-term investors despite short-term overbought signals. He views recent governance-led supply changes as an additional driver for institutional interest. "With ongoing innovation and on-chain traction, I expect further growth opportunities to emerge for INJ," says Karapetjanc.

Parshwa Turakhiya, analyst, observes strong upside sentiment in INJ driven by surging volume and bullish intraday action. He notes that the technical setup is favorable above $3.59 support but warns that overextended oscillators signal a risk of near-term consolidation. Turakhiya believes momentum traders can watch the $4.51 breakout, but tactically tight stops are advised given volatility. "Sentiment is hot right now, but breakout chasers should stay nimble as any dip below $4.13 could shift the tone quickly," Turakhiya advises.

Overbought signals mounting as bullish momentum meets resistance

INJ/USD is trading at $4.28, positioning it well above the 20-day ($3.59) and 50-day ($3.22) moving averages, but still below the 200-day moving average at $4.53. This setup confirms bullish momentum in the short and medium term, with some longer-term resistance still looming from the 200-day level; the nearest dynamic support comes from the Ichimoku Kijun at $3.59, while resistance is likely seen near $4.50 – $4.53. Momentum indicators show a positive bias: the MACD and Average Directional Index (ADX) both forecast a buy, confirming strong upside pressure. The Relative Strength Index (RSI) at 72.80, Stochastic RSI at 100, and Commodity Channel Index (CCI) at 171.32 all signal overbought conditions, indicating the risk of a pullback grows as the rally extends. Bull/Bear Power (BBP) at 0.55 reflects buyer dominance in intraday action, with an overbought warning flag. Today's action features an upside gap of about $0.34 and a 10.05% move up, putting the price in the middle of its intraday range. Intraday volatility stands at 3.55%. There has been clear momentum after the open, with buying strength persisting, yet signs of speculative excess are starting to emerge. Oscillators point to overbought territory even as trend momentum remains bullish.

Earlier, analysts noted that Injective was exhibiting cautious short-term momentum but remained constrained by persistent long-term downtrends. The current technical picture reinforces the emergence of renewed bullish momentum while highlighting overbought risks, making the $4.51 resistance level a critical threshold to monitor for any sustained breakout.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.